Market Research Report
North America Multiplex Assay Market Forecast 2019-2027
|North America Multiplex Assay Market Forecast 2019-2027|
Published: March 12, 2019
Content info: 89 Pages
Delivery time: 2-3 business days
The multiplex assay market in the North American region is estimated to record a CAGR of 6.21% over the forecast period of 2019-2027. The factors leading to the growth in the market are an increase in the field of research and development for detection of various chronic diseases like cancer and cardiovascular diseases and treatment, rise in the use of personalized medicines used for increasing safety and efficiency of therapies, and benefits, such as low operational cost and reduced labor, as multiplex assays are the most economical assays.
The region of North America for the study of the multiplex assay market is divided into the US and Canada. The Canada market is dominated by the prevalence of cancer and government investments in the research and development for the discovery of drugs and treatment. As there is a steady rise in the disease in the region, the demand for multiplex assay will increase in the region as it is an important oncology tool. The huge investments by the government for the discovery and development of drugs are expected to make the market grow substantially in the region.
Some of the major companies in the market are Agilent Technologies, Inc, Becton, Dickinson, and Company, Bio-Rad Laboratories, Inc. , and Bio-Techne Corporation.